United States

X4 Pharmaceuticals is a biopharmaceutical company that develops and commercializes novel therapeutics for rare diseases. Its lead product candidate, mavorixafor, is in Phase III clinical trial for the treatment of patients with various syndromes. The company is also developing CXCR4 antagonists for the treatment of brain cancers and primary immunodeficiencies. X4 Pharmaceuticals has a license agreement with Abbisko Therapeutics to develop mavorixafor in combination with other agents in oncology indications. The company was founded in 2010 and is headquartered in Boston, Massachusetts.

X4 Pharmaceuticals

Rare disease therapeutics, Phase III trial.

Google

Product Manager

Data Scientist

X4 Pharmaceuticals

X4 Pharmaceuticals Open Jobs

Are you ready to level up your career? Check out these open roles at X4 Pharmaceuticals.